Interventions: Procedure: Biopsy; Procedure: Computed Tomography; Other: Fluorine F 18 Tetrafluoroborate; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Procedure: Planar Imaging; Procedure: Positron Emission Tomography; Biological: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter; Drug: Ruxolitinib; Drug: Ruxolitinib Phosphate; Procedure: Single Photon Emission Computed Tomography; Drug: Technetium Tc-99m Sodium Pertechnetate
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.